Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.

Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check40 days agoChange DetectedThe site revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 is displayed on the page, with no changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page now shows Revision: v3.4.1 instead of Revision: v3.4.0. This is a metadata update at the top of the page and does not affect study content.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded UI and metadata changes: a Show glossary option appears, and new labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' are shown. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed or updated.SummaryDifference0.3%

Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.